| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01488253 Details | 2015-04-03 Interventional | 2 | 3 | MTOR Inhibitors Sirolimus Tacrolimus Temsirolimus Leukemia Leukemia, Myelo… Leukemia, Myelo… Leukemia, Myelo… Leukemia, Myelo… Myelodysplastic… Acute Leukemia … Leukemia, Myelo… | We could not receive the support from the national medical insurance owing to the changed
policy of the government for clincal trials. - | |||
| NCT01244711 Details | 2015-04-03 Interventional | 4 | 1 | Quetiapine Fuma… Anxiety Disorde… Depression Depressive Diso… Depressive Diso… Generalized Anx… Major Depressio… | Terminated: recruiting or enrolling participants has halted prematurely - | |||
| NCT01203228 NCT00682396 2005-002011-24 Details | 2015-04-03 Interventional | 3 | 129 | Busulfan Cyclophosphamid… Fludarabine pho… Myelodysplastic… Secondary Acute… | - - | |||
| NCT00247130 Details | 2015-04-03 Interventional | 4 | 0 | Omeprazole Ranitidine Ranitidine bism… Peptic Ulcer Ulcer Peptic Ulcers | Superiority of iv omeprazole to ranitidine has already been proven by others. - | |||
| NCT00131391 Details | 2015-04-03 Interventional | 3 | 2400 | N-(3-(4-chlorop… Obesity | The overall profile does not support development for obesity - | |||
| NCT01267266 Details | 2015-04-01 Interventional | 2 | 31 | Hydrocortisone Saracatinib Prostatic Neopl… Hormone-resista… Recurrent Prost… Stage IV Prosta… | Per protocol, study was terminated due to low rate of randomized patients. - | |||
| NCT00930345 Details | 2015-04-01 Interventional | 4 | 33 | Sunitinib Carcinoma Carcinoma, Rena… Metastatic Rena… | - - | |||
| NCT02129400 2014-000973-38 Details | 2015-03-31 Interventional | 3 | 36 | Anesthetics Xenon Healthy Volunte… | The analysis of the blood samples was much expensive than calculated. The recruitment had to be
stopped after 36 study participants. - | |||
| NCT01689896 Details | 2015-03-31 Interventional | 4 | 0 | Testosterone Hypogonadism Low Testosteron… Pain | Difficult to obtain placebo - | |||
| NCT00670956 Details | 2015-03-30 Interventional | 1/2 | 1 | Betamethasone Congenital Abno… Cystic Adenomat… Congenital Cyst… | Recruitment has been poor. Study drug is being offered as part of standard care of women
carrying a pregnancy diagnosed with CCAM - | |||
| NCT00254904 Details | 2015-03-30 Interventional | 3 | 839 | Cisplatin Gemcitabine Carcinoma, Non-… | See Termination Reason in Detailed Description - | |||
| NCT00254891 Details | 2015-03-30 Interventional | 3 | 828 | Albumin-Bound P… Carboplatin Paclitaxel Carcinoma, Non-… | See Termination Reason in Detailed Description - | |||
| NCT00210392 Details | 2015-03-30 Interventional | 2 | 12 | Bortezomib Lymphoma Lymphoma, B-Cel… Lymphoma, Mucos… | After IELSG25A study amendment, patients subject of the present study were eligible for
inclusion in the IELSG25A study - | |||
| NCT02108548 2013-004357-25 Details | 2015-03-27 Interventional | 1 | 89 | Naproxen Healthy Subject… Pharmacodynamic… Pharmacokinetic… | Gastrointestinal safety findings - | |||
| NCT01755702 Details | 2015-03-27 Interventional | 2/3 | 66 | Acetaminophen Caffeine Ibuprofen Headache Tension-Type He… Headache, Tensi… | Study was terminated due to unforeseen difficulties with subject recruitment. No safety issues
were identified in the study with this new formulation. - | |||
| NCT00881114 Details | 2015-03-27 Interventional | 2 | 0 | Cetuximab Head and Neck N… Head and Neck C… | Investigator decided it was not feasible to conduct this study - | |||
| NCT00618358 Details | 2015-03-27 Interventional | 1 | - | Gelatin Sponge,… Thrombin Arteriovenous A… | Sponsor - Confluent Surgical terminated study re: surgical techniques Letter dated 4/31/2008 - | |||
| NCT01440127 Details | 2015-03-26 Interventional | 1 | 9 | Metformin Colorectal Neop… Colon Cancer | Unable to accrue all planned subjects in a timely fashion, but data collected will still be
analyzed. - | |||
| NCT00077961 Details | 2015-03-26 Interventional | 1/2 | - | Alemtuzumab Lymphoma Lymphoma, Non-H… Non-Hodgkin's L… | - - | |||
| NCT02398136 Details | 2015-03-25 Interventional | 2/3 | 0 | Ketamine Midazolam Stress Disorder… PTSD | FDA and IRB recommended different mode of medication administration - |